Suspected Yellow Fever (Clinical Diagnosis)
Yellow fever diagnosis is based on a compatible acute clinical syndrome plus epidemiologic context, with laboratory testing required for case confirmation. [1,2] Clinical manifestations are often nonspecific early and can overlap with other acute febrile illnesses. [2]
Clinical Presentation Supporting the Diagnosis
Yellow fever should be suspected in patients with acute onset fever plus signs of hepatic dysfunction or hemorrhagic disease in the setting of exposure risk. [1] Classically described severe disease includes jaundice and hemorrhage. [1]
Epidemiologic Assessment
Yellow fever risk assessment should incorporate travel or residence in endemic areas and presence of an outbreak. [1,3] Vaccination history should be obtained because recent vaccination can affect serologic interpretation. [1]
Laboratory Confirmation Framework
Laboratory confirmation is achieved by detecting yellow fever–specific immune responses and/or viral RNA in appropriate specimens. [1,4] Virus-specific IgM and neutralizing antibodies are used for serologic confirmation. [1] RT-PCR detects viral RNA during the early phase of illness and provides definitive confirmation when positive. [4,1] A negative RT-PCR does not rule out yellow fever because of transient viremia. [1]
Specimen Timing Considerations
Viral RNA can be detected in serum during the first ~10 days after symptom onset by molecular methods. [4] In severe cases, viral RNA detection may extend beyond 10 days. [4]
How Case Classification Is Applied in Practice
Serologic testing interpretation requires consideration of yellow fever vaccination history because IgM responses can persist after vaccination. [1] When interpretation is limited by vaccination or assay cross-reactivity, case classification and confirmation may require additional testing strategies such as paired serology or further testing through reference laboratories. [1,5]
Common Diagnostic Pitfalls to Avoid
IgM positivity should be interpreted in the context of vaccination history because vaccine-derived IgM can persist and cannot differentiate wild-type from vaccine virus by available routine tests. [1] Relying on a negative nucleic-acid result alone can miss cases because RT-PCR negativity does not exclude infection. [1] Early clinical nonspecificity can delay recognition without exposure-risk assessment. [2]
Referral and Testing Logistics
Submission of specimens to appropriate public health or reference laboratories is recommended when yellow fever is suspected and confirmation testing is needed. [1] Clinical laboratory guidance supports a diagnostic approach that integrates clinical features, epidemiology, vaccination history, and laboratory results for final confirmation. [3,5]